Evidence map›Paper›PMID 38642998›Full record

ArticleBMJ open2024

Feasibility of a screening and prevention procedure for risks associated with dysphagia in older patients in geriatric units: the DYSPHAGING pilot study protocol.

Olivier Durlach, Stéphanie Tripoz-Dit-Masson, Nicolas Massé-Deragon, Fabien Subtil, Zeinabou Niasse-Sy, Chloé Herledan, Laure Guittard, Karine Goldet, Salima Merazga, Margaux Chabert and 4 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05734586 (Feasibility Study of Screening for Sarcopenic Dysphagia and the Implementation of Measures to Prevent Its Complications in Geriatric or Institutionalized Patients Aged ≥ 70 Years.), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05734586 naunknown statusnot on this map

Feasibility Study of Screening for Sarcopenic Dysphagia and the Implementation of Measures to Prevent Its Complications in Geriatric or Institutionalized Patients Aged ≥ 70 Years.

TypeinterventionalSponsorHospices Civils de LyonRan2023 to 2024Enrolled102ConditionsSwallowing Disorder, Sarcopanic DysphagiaArmsEAT-10 (Eating assessment Tool) screening questionnaire, Protective measures for the upper airways
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Olivier DurlachInstitut du Vieillissement, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Stéphanie Tripoz-Dit-MassonCentre de Recherche Clinique Vieillissement, Cerveau, Fragilité, Hôpital des Charpennes, Hospices Civils de Lyon, Villeurbanne, Auvergne-Rhône-Alpes, France.
Nicolas Massé-DeragonInstitut du Vieillissement, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Fabien SubtilCNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Lyon, Universite Claude Bernard Lyon 1, Villeurbanne, Auvergne-Rhône-Alpes, France.
Zeinabou Niasse-SyInstitut du Vieillissement, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Chloé HerledanUnité de Pharmacie clinique oncologique, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Laure GuittardPôle de Santé Publique, Service Recherche et Epidémiologie cliniques, Hospices Civils de Lyon, 69008 Lyon, France.
Karine GoldetCentre de Recherche Clinique Vieillissement, Cerveau, Fragilité, Hôpital des Charpennes, Hospices Civils de Lyon, Villeurbanne, Auvergne-Rhône-Alpes, France.
Salima MerazgaDirection à la Recherche en Santé, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Margaux ChabertDirection à la Recherche en Santé, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Anne SuelDirection à la Recherche en Santé, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
David DaydePlateforme Transversale de Recherche de l'ICHCL, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Marion MerdinianInstitut du Vieillissement, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
Claire FalandryInstitut du Vieillissement, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France claire.falandry@chu-lyon.fr.ORCID 0000-0001-7267-4723
Hospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDysphagia, particularly sarcopenic dysphagia, is frequent in frail older patients. Sarcopenic dysphagia is a swallowing disorder caused by sarcopenia, corresponding to a loss of muscle mass and strength. It frequently leads to inhalation and to the decrease of food intake, leading the patient to enter a vicious circle of chronic malnutrition and frailty. The awareness of the major health impacts of sarcopenic dysphagia is recent, explaining a low rate of screening in the population at risk. In this context, methods of prevention, evaluation and intervention of sarcopenic dysphagia adapted to the most at-risk population are necessary.

methodsThe DYSPHAGING (dysphagia & aging) pilot study is a prospective, multicentre, non-comparative study aiming to estimate the feasibility of an intervention on allied health professionals using the DYSPHAGING educational sheet designed to implement a two-step procedure 'screen-prevent' to mitigate swallowing disorders related to sarcopenic dysphagia. After obtaining oral consent, patients are screened using Eating Assessment Tool-10 Score. In case of a score≥2, procedures including positional manoeuvres during mealtimes, food and texture adaptation should be implemented. The primary endpoint of the study is the feasibility of this two-step procedure (screening-prevention measures) in the first 3 days after patient's consent.The study will include 102 patients, with an expected 10% rate of non-analysable patients. Participants will be recruited from acute geriatric wards, rehabilitation centres and long-term care units, with the hypothesis to reach a feasibility rate of 50% and reject a rate lower than 35%. ETHICS AND DISSEMINATION: The study protocol was approved according to French legislation (CPP Ile-de-France VII) on 15 February 2023. The results of the primary and secondary objectives will be published in peer-reviewed journals. TRIAL REGISTRATION NUMBER: NCT05734586.

Indexed as

Deglutition DisordersSarcopeniaAgedFeasibility StudiesHumansPilot ProjectsProspective StudiesGERIATRIC MEDICINENursing CareNUTRITION & DIETETICSOTOLARYNGOLOGYPUBLIC HEALTH

Identifiers

PMID38642998
PMCPMC11033636
OpenAlexW4394980332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.